Molecule Information
General Information of the Molecule (ID: Mol02027)
Name |
Ribosomal tetracycline resistance protein tet (TET(44))
,Clostridioides difficile
|
||||
---|---|---|---|---|---|
Synonyms |
BGV00_19340; BN1095_620053; BN1096_520088; BN1097_680096; E5F26_13010; E5F27_11275; E5F28_08645; E5F29_03080; E5F30_14860; E5F31_09375; E5F32_08895; E5F33_19320; E5F34_11670; E5F35_02795; E5F36_15070; E5F37_19425; E5F38_19050; E5F39_10665; E5F40_01415; E5F41_11825; E5F42_18275; E5F43_02490; E5F44_06595; E5F45_10465
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
TET(44)
|
||||
Gene ID | |||||
Sequence |
MKTNNMKQAILSSATNLIAKNGVQNTSLADIAKDVNISKGTLYYHYASKDDIIYDIADTH
LEVITSAILNCVKNVKSKNSQIEMVNLILEKISTIESRGRVHMYLICEAITSNNDLKERI RLKYIEWRTTLKSEIVESLEKYNSSENEQDAESFSFLLMSIVDGLVVQSLLKTEKIPYEN IASFLVNHWI Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
ADTT: Aberration of the Drug's Therapeutic Target
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Tetracycline
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Aberration of the Drug's Therapeutic Target (ADTT) | ||||
Disease Class: Human immunodeficiency virus infection | [1] | |||
Resistant Disease | Human immunodeficiency virus infection [ICD-11: 1C62.0] | |||
Resistant Drug | Tetracycline | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
Mechanism Description | Of the resistance mechanisms, C. difficile produces ribosomal protection protein that impedes the attachment of the drug to a ribosome. The TetM protein that functions as ribosomal protectant has been identified in TET-resistant C. difficile strains, whereas the presence of other Tet proteins such as Tet(W) and Tet(44) has also been recognized. The TetM exhibits homology to EF-G and shares the same binding region in a ribosome. The binding of the TetM protein to a ribosome accompanying with the GTP hydrolysis allows conformational change of the ribosome, resulting in the dissociation of TET from its binding site. Cellular protein synthesis is then recovered through the binding of EF-G after the release of hydrolysed TetM. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.